The china regulatory risks were significantly reduced months ago, hence the surge up from around $2 back... so are you saying that no new information should be incorporated in analysts reports when it comes about? You're clutching at straws here.
You need to check out what Synlaits infant formula production forecast is for FY18 compared to FY17, I'm sure you'll have a different outlook then.
Goldman sachs comment, page-18
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.78 |
Change
-0.035(0.51%) |
Mkt cap ! $4.962B | |||
| Open | High | Low | Value | Volume |
| $6.80 | $6.92 | $6.76 | $3.813M | 558.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 6833 | $6.77 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.78 | 10050 | 12 |
View Market Depth
| Last trade - 11.29am 10/07/2024 (20 minute delay) ? |
| A2M (ASX) Chart |